Successful treatment of three elderly patients suffering from prolonged delirium using the cholinesterase inhibitor rivastigmine;Succesvolle behandeling van 3 langdurig delirante oudere patiënten met de cholinesteraseremmer rivastigmine

Nederlands Tijdschrift voor Geneeskunde

Volumn 148, Issue 30, 2004, Pages 1501-1504

  Kalisvaart, C J ^a   Boelaarts, L ^a   De Jonghe, J F M ^a   Hovinga, I M ^a   Kat, M G ^a  

^a Location Alkmaar   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CHOLINESTERASE INHIBITOR; HALOPERIDOL; RIVASTIGMINE;

AGED; CASE REPORT; DELIRIUM; DRUG EFFICACY; DRUG TOLERABILITY; GENERAL HOSPITAL; HUMAN; MALE; NETHERLANDS; PATHOPHYSIOLOGY; REVIEW;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; CARBAMATES; CHOLINESTERASE INHIBITORS; DELIRIUM; HALOPERIDOL; HOSPITALIZATION; HUMANS; MALE; PHENYLCARBAMATES; TREATMENT OUTCOME;

EID: 3343020131     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Weele GM van der, Olde Rikkert MG, Eizenga WH, Assendelft WJ. Samenvatting van de standaard 'Delier bij ouderen' van het Nederlands Huisartsen Genootschap. Ned Tijdschr Geneeskd 2003;147: 965-9.
2. Bucht G, Gustafson Y, Sandberg O. Epidemiology of delirium. Dement Geriatr Cogn Disord 1999;10:315-8.
3. Cole MG, Primeau FJ, Elie LM. Delirium: prevention, treatment, and outcome studies. J Geriatr Psychiatry Neurol 1998;11:126-37.
4. Rockwood K. The occurrence and duration of symptoms in elderly patients with delirium. J Gerontol 1993;48:M162-6.
5. Mast RC van der. Postoperative delirium. Dement Geriatr Cogn Disord 1999;10:401-5.
6. Marcantonio ER, Flacker JM, Michaels M, Resnick NM. Delirium is independently associated with poor functional recovery after hip fracture. J Am Geriatr Soc 2000;48:618-24.
7. McCusker J, Cole M, Dendukuri N, Han L, Belzile E. The course of delirium in older medical inpatients: a prospective study. J Gen Intern Med 2003;18:696-704.
8. Williams-Russo P, Urquhart BL, Sharrock NE, Charlson ME. Post-operative delirium: predictors and prognosis in elderly orthopedic patients. J Am Geriatr Soc 1992;40:759-67.
9. Practice guideline for the treatment of patients with delirium. American Psychiatric Association. Am J Psychiatry 1999;156: 1-20.
10. Cole MG, McCusker J. Treatment of delirium in older medical inpatients: a challenge for geriatric specialists. J Am Geriatr Soc 2002;50:2101-3.
11. Meagher DJ, O'Hanlon D, O'Mahony E, Casey PR. The use of environmental strategies and psychotropic medication in the management of delirium. Br J Psychiatry 1996;168:512-5.
12. Cummings JL. Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations. Am J Geriatr Psychiatry 2003; 11:131-45.
13. McKeith I, del Ser T, Spano P, Emre M, Wesnes K, Anand R, et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 2000;356:2031-6.
14. Wild R, Pettit T, Bums A. Cholinesterase inhibitors for dementia with Lewy bodies. Cochrane Database Syst Rev 2003;CD003672.
15. Rupreht J, Schneck HJ, Dworacek B. Physostigmine-recent pharmacologic data and their significance for practical use. Anaesthesiol Reanim 1989;14:235-41.
16. Stem TA. Continuous infusion of physostigmine in anticholinergic delirium: case report. J Clin Psychiatry 1983;44:463-4.
17. Dautzenberg PL, Wouters CJ, Oudejans I, Samson MM. Rivastigmine in prevention of delirium in a 65 years old man with Parkinson's disease. Int J Geriatr Psychiatry 2003;18:555-6.
18. Fischer P. Successful treatment of nonanticholinergic delirium with a cholinesterase inhibitor. J Clin Psychopharmacol 2001;21:118.
19. Wengel SP, Roccaforte VM, Burke WJ. Donepezil improves symptoms of delirium in dementia: implications for future research. J Geriatr Psychiatry Neurol 1998;11:159-61.
20. Wengel SP, Burke WJ, Roccaforte WH. Donepezil for postoperative delirium associated with Alzheimer's disease. J Am Geriatr Soc 1999;47:379-80.
21. Manos PJ. Neuropathogenesis of delirium. Psychosomatics 1995;36: 156-7.
22. Moore AR, O'Keeffe ST. Drug-induced cognitive impairment in the elderly. Drugs Aging 1999;15:15-28.
23. O'Keeffie ST. The neuropathogenesis of delirium. Aging 1997;9: 38-9.
24. Trzepacz PT. Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine. Semin Clin Neuropsychiatry 2000;5:132-48.
25. Trzepacz PT, Mast RC van der. The neuropathofysiology of delirium, In: Lindesay J, Rockwood K, Macdonald AJ, editors. Delirium in old age. New York: Oxford University Press; 2002. p. 51-90.
26. Tune LE, Egeli S. Acetylcholine and delirium. Dement Geriatr Cogn Disord 1999;10:342-4.
27. Lemstra AW, Eikelenboom P, Gool WA van. Het cholinerg deficiëntiesyndroom als indicatie voor cholinesteraseremmers. Ned Tijdschr Geneeskd 2003;147:2201-3.
28. Hekster YA, Lisman JA, Heijmenberg GM, Koopmans PP, Loenhout JWA. Het voorschrijven en afleveren van geneesmiddelen buiten de geregistreerde indicatie. Geneesmiddelen Bulletin 2000;34:139-47.